Skip to main content
. 2016 Aug 1;7(37):59834–59844. doi: 10.18632/oncotarget.10975

Figure 2. Kaplan–Meier survival analysis for all 327 patients with triple negative breast cancer according to the 17-3′UTR-based classifier stratified by clinicopathological risk factors.

Figure 2

A, B. Age. C, D. Lymph node status. E, F. Tumor size. P-values were calculated using a log-rank test.